DI PRIMA, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 164
EU - Europa 59
AS - Asia 53
AF - Africa 1
SA - Sud America 1
Totale 278
Nazione #
US - Stati Uniti d'America 162
SG - Singapore 30
IT - Italia 26
CN - Cina 11
BG - Bulgaria 8
IN - India 8
SE - Svezia 7
DE - Germania 3
RU - Federazione Russa 3
BE - Belgio 2
CA - Canada 2
NL - Olanda 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
CH - Svizzera 1
DK - Danimarca 1
ID - Indonesia 1
IS - Islanda 1
JP - Giappone 1
LU - Lussemburgo 1
PE - Perù 1
PL - Polonia 1
TG - Togo 1
Totale 278
Città #
Singapore 24
Chandler 22
Ashburn 17
Fairfield 16
Santa Clara 13
Sofia 8
Wilmington 7
Houston 6
Seattle 6
Cambridge 5
Cagliari 4
New York 4
Princeton 4
Rome 4
Woodbridge 4
Millbury 3
Bremen 2
Brussels 2
Moscow 2
Palestrina 2
San Paolo di Civitate 2
Stockholm 2
Accadia 1
Amsterdam 1
Ann Arbor 1
Bologna 1
Copenhagen 1
Dhaka 1
Frankfurt am Main 1
Hangzhou 1
Jakarta 1
Keflavik 1
Laurel 1
Lawrence 1
Lima 1
Lomé 1
Los Angeles 1
Luxembourg 1
Milan 1
Norwalk 1
Ottawa 1
San Diego 1
Shanghai 1
Tirana 1
Tokyo 1
Toronto 1
Trento 1
Washington 1
Yerevan 1
Zurich 1
Totale 187
Nome #
Prognostic significance of PET/CT in patients with chronic lymphocytic leukemia (CLL) treated with frontline chemoimmunotherapy 71
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors 63
null 28
Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice 27
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia. is it time to introduce it in the clinical practice? 27
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab 19
null 17
null 16
Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up 11
The advantages and risks of ruxolitinib for the treatment of polycythemia vera 9
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients 8
Hemoglobin Changes during Long-Lasting Frontline Treatment with Tyrosine-Kinase Inhibitors in Patients with Chronic Myeloid Leukemia 8
Totale 304
Categoria #
all - tutte 1.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 5 22 6 2 2 0 0 8 4
2021/202249 5 0 0 2 12 3 2 2 6 1 9 7
2022/202364 11 8 3 9 10 4 1 8 7 0 2 1
2023/202473 7 7 4 5 7 14 0 3 0 13 3 10
2024/202569 4 6 11 19 23 6 0 0 0 0 0 0
Totale 304